First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval

by admin | May 5, 2026 | Health

Spread the love

mCombriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains and SARS-CoV-2 targets.
Medscape News Europe

← First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval With USAID gone, Indo-Pacific allies face the fallout →

Written By

Written by Albert Pham, News Curator and Blogger

Cocaine Trade Booms Despite U.S. Airstrikes and Drug Crackdown

Oct 13, 2026 | albertpham, Economy_finances, Health

The global cocaine trade continues to expand despite U.S. airstrikes against suspected smugglers. Discover why trafficking networks remain resilient.

McDonald’s Chicken and Beverage Strategy: Global Growth Plans Through 2030

Oct 12, 2026 | albertpham, Economy_finances, Health

McDonald’s is expanding its chicken menu and specialty beverages to gain market share by 2030, challenge competitors and attract more customers.

Endometriosis in Canada: Why Women Are Seeking Treatment in Mexico

Oct 12, 2026 | albertpham, Health, Travel

Canadian women are travelling to Mexico for endometriosis treatment after facing long wait times, highlighting gaps in specialist care and women’s health services.

First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval

Written By

Related Posts

Cocaine Trade Booms Despite U.S. Airstrikes and Drug Crackdown

McDonald’s Chicken and Beverage Strategy: Global Growth Plans Through 2030

Endometriosis in Canada: Why Women Are Seeking Treatment in Mexico

0 Comments

Explore More

Connect With Us

Quick Links

Legal

Stay Updated